The Patent Finder

Terms ending in 2033

Bioamber Inc.

Every in-force patent on Bioamber Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,605,285Compositions and Methods for Succinate Production
In force
 · High confidence
Bioamber Inc.In forceHigh confidence
US 9,018,127Preparation of Catalyst for Selective Hydrogenation of Hydrogenatable Precursors
In force
 · High confidence
Lcy Biosciences Inc.In forceHigh confidence
US 9,850,507Yeast Cells Having Reductive TCA Pathway from Pyruvate to Succinate and Overexpressing an Exogenous NAD(P)+ Transhydrogenase Enzyme
In force
 · High confidence
Bioamber Inc.In forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Bioamber Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited